At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 100 enrolled
Drug / intervention
Omega 3 fatty acids +1 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Effects of the Supplementation With Omega 3 Fatty Acids in Patients With Chronic Renal Disease
In Brief
A Phase 3 clinical trial evaluating Omega 3 fatty acids and Corn oil for Renal Insufficiency, Chronic. Completed, enrolled 100 participants across 1 site.
Detailed Summary
To study the tolerance and efficacy of an omega 3 fatty acids supplement on renal and vascular function and inflammatory parameters in patients with chronic renal disease
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRenal Insufficiency, Chronic
CountriesChile
CollaboratorsServicio de Salud Metropolitano Oriente
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartSep 2017
Primary CompletionOct 2018
TodayJul 2026
First PostedSep 12, 2017
Enrollment StartSep 20, 2017
Primary CompletionOct 31, 2018
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 8.8 years ago
Interventions
Omega 3 fatty acidsdietary
Omega 3 fatty acids will be provided in a dose of 3.7 g/day, that should be enough to rise red blood cell levels of eicosapentanoic and docosahexanoic acids
Corn oildietary
Corn oil will be the placebo comparator for omega 3 fatty acids supplement